In spring 2020, the French High Authority for Health, HAS, has announced the call for public consultation with the purpose of developing a draft functional classification of the digital solutions (for example, health apps, web platforms). The call ends on June 30, 2020.

As part of efforts to increase the effectiveness of measures to prevent the spread of coronavirus infection, the Ministry of Health of Russia informed suppliers, manufacturers and executive authorities that, subject to the rules for submitting documents for registration of medical devices intended for the diagnosis of coronavirus infection, their registration will be carried out as soon as possible deadlines.

On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has researched current evidence-based guidelines on the chronic obstructive pulmonary disease (COPD), summarized their recommendations and checked the need for updates for the COPD disease management program (DMP).

MTRC has released the new video on the Market Access Insider Youtube channel. Oleg Borisenko spoke to Mr. Luigi Mazzei, Country Director at Edwards Lifesciences about market access for medical devices in Italy.

In April 2020, the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) introduced four new nomenclature codes for stereotactic radiotherapy (Belgian Monitor of April 27, 2020). Physicians also must register data on provided stereotactic radiotherapy series in the specific module of Cancer Registry Foundation.

On 24 April 2020, NHSX, the Department of Health and Social Care (DHSC), and the Ministry for Housing Communities and Local Government (MHCLG) have announced 18 innovative digital solutions being awarded up to £25,000 under the TechForce19 challenge.

The German Society for Neurology (DGN) has released a new version of the S1 guideline "Diagnostics and therapy of neurogenic bladder disorders." It is valid until January 2025.

MTRC has released the new video on the Market Access Insider Youtube channel. Oleg Borisenko spoke to Mr. Andrea Zanella, CEO of DIANAX S.r.l. about market access for in-vitro diagnostic tests in Italy.

Thirteen new MELs (DRGs) were introduced into the LKF 2020 model for the inpatient and outpatient settings.

On May 7, 2020, the National Association of Statutory Health Insurance Physicians (KBV) announced that antibodies testing for COVID-19 will be reimbursement. The findings of the test must be communicated within 24 hours.

In late April 2020, the European Parliament has postponed the come-into-force of the EU Medical Device Regulation (MDR) by one year. Medical devices can thus be placed on the market for another year under the previous regulations. The end date of the transition period will remain May 26, 2024.

On 10 April 2020, the Reimbursement Commission made changes to the SUT regarding response to the COVID-19 pandemic and introduced procedure codes regarding pandemic care service (including pandemic care service for ICU care and immune plasma supply and application).